Metabolomics: a promising diagnostic and therapeutic implement for breast cancer

Zhanghan Chen,1 Zehuan Li,1 Haoran Li,2 Ying Jiang11Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of China; 2Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of China...

Full description

Bibliographic Details
Main Authors: Chen Z, Li Z, Li H, Jiang Y
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/metabolomics-a-promising-diagnostic-and-therapeutic-implement-for-brea-peer-reviewed-article-OTT
id doaj-d08f930e96fc4bb383449944736d1f95
record_format Article
spelling doaj-d08f930e96fc4bb383449944736d1f952020-11-24T21:24:08ZengDove Medical PressOncoTargets and Therapy1178-69302019-08-01Volume 126797681148001Metabolomics: a promising diagnostic and therapeutic implement for breast cancerChen ZLi ZLi HJiang YZhanghan Chen,1 Zehuan Li,1 Haoran Li,2 Ying Jiang11Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of China; 2Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of ChinaCorrespondence: Ying JiangDepartment of General Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, People’s Republic of ChinaTel +86 216 404 1990Fax +86 216 403 8472Email jiang.ying3@zs-hospital.sh.cnAbstract: Breast cancer (BC) is the most commonly diagnosed cancer among women and the leading cause of cancer death. Despite the advent of numerous diagnosis and treatment methods in recent years, this heterogeneous disease still presents great challenges in early diagnosis, curative treatments and prognosis monitoring. Thus, finding promising early diagnostic biomarkers and therapeutic targets and approaches is meaningful. Metabolomics, which focuses on the analysis of metabolites that change during metabolism, can reveal even a subtle abnormal change in an individual. In recent decades, the exploration of cancer-related metabolomics has increased. Metabolites can be promising biomarkers for the screening, response evaluation and prognosis of BC. In this review, we summarized the workflow of metabolomics, described metabolite signatures based on molecular subtype as well as reclassification and then discussed the application of metabolomics in the early diagnosis, monitoring and prognosis of BC to offer new insights for clinicians in breast cancer diagnosis and treatment.Keywords: diagnosis, biomarkers, treatment, metaboliteshttps://www.dovepress.com/metabolomics-a-promising-diagnostic-and-therapeutic-implement-for-brea-peer-reviewed-article-OTTDiagnosisBiomarkersTreatmentMetabolites
collection DOAJ
language English
format Article
sources DOAJ
author Chen Z
Li Z
Li H
Jiang Y
spellingShingle Chen Z
Li Z
Li H
Jiang Y
Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
OncoTargets and Therapy
Diagnosis
Biomarkers
Treatment
Metabolites
author_facet Chen Z
Li Z
Li H
Jiang Y
author_sort Chen Z
title Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
title_short Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
title_full Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
title_fullStr Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
title_full_unstemmed Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
title_sort metabolomics: a promising diagnostic and therapeutic implement for breast cancer
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2019-08-01
description Zhanghan Chen,1 Zehuan Li,1 Haoran Li,2 Ying Jiang11Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of China; 2Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of ChinaCorrespondence: Ying JiangDepartment of General Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, People’s Republic of ChinaTel +86 216 404 1990Fax +86 216 403 8472Email jiang.ying3@zs-hospital.sh.cnAbstract: Breast cancer (BC) is the most commonly diagnosed cancer among women and the leading cause of cancer death. Despite the advent of numerous diagnosis and treatment methods in recent years, this heterogeneous disease still presents great challenges in early diagnosis, curative treatments and prognosis monitoring. Thus, finding promising early diagnostic biomarkers and therapeutic targets and approaches is meaningful. Metabolomics, which focuses on the analysis of metabolites that change during metabolism, can reveal even a subtle abnormal change in an individual. In recent decades, the exploration of cancer-related metabolomics has increased. Metabolites can be promising biomarkers for the screening, response evaluation and prognosis of BC. In this review, we summarized the workflow of metabolomics, described metabolite signatures based on molecular subtype as well as reclassification and then discussed the application of metabolomics in the early diagnosis, monitoring and prognosis of BC to offer new insights for clinicians in breast cancer diagnosis and treatment.Keywords: diagnosis, biomarkers, treatment, metabolites
topic Diagnosis
Biomarkers
Treatment
Metabolites
url https://www.dovepress.com/metabolomics-a-promising-diagnostic-and-therapeutic-implement-for-brea-peer-reviewed-article-OTT
work_keys_str_mv AT chenz metabolomicsapromisingdiagnosticandtherapeuticimplementforbreastcancer
AT liz metabolomicsapromisingdiagnosticandtherapeuticimplementforbreastcancer
AT lih metabolomicsapromisingdiagnosticandtherapeuticimplementforbreastcancer
AT jiangy metabolomicsapromisingdiagnosticandtherapeuticimplementforbreastcancer
_version_ 1725989449743990784